SCHEMBL5117735

SCHEMBL5117735

CC(=O)Nc1cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.44
THRB P10828 2/20 0.44
RHOC P08134 1/20 0.40
RHOA P61586 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
DHODH Q02127 2/20 0.37
MRGPRX4 Q96LA9 2/20 0.36
NR2E1 Q9Y466 1/20 0.36
LMNA P02545 1/20 0.36
P2RX1 P51575 1/20 0.36
JUN P05412 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SENP5 Q96HI0 1/20 0.36
SENP2 Q9HC62 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722769 0.91 THRA (0.49) THRATHRBRHOCRHOAMRGPRX4
SCHEMBL5106633 0.90 RHOC (0.43) THRATHRBRHOCRHOAMEN1
SCHEMBL4934248 0.90 THRA (0.44) THRATHRBRHOCRHOAMEN1
SCHEMBL5104851 0.90 RHOC (0.42) RHOCRHOAHTTL3MBTL1MRGPRX4
SCHEMBL4924564 0.90 THRA (0.45) THRATHRBRHOCRHOAMEN1
SCHEMBL5111593 0.89 THRA (0.42) THRATHRBRHOCRHOAMEN1
SCHEMBL4346172 0.88 THRA (0.47) THRATHRBRHOCRHOAMEN1
SCHEMBL5116634 0.87 BRD4 (0.39) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL5109507 0.86 THRA (0.42) THRATHRBRHOCRHOAMEN1
SCHEMBL5722548 0.86 PPARD (0.39) THRATHRBRHOCRHOAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885RHOC 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.